Bellevue Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.2M Sell
252,744
-164,143
-39% -$10.8M 0.34% 59
2026
Q1
$29.7M Sell
416,887
-7,627
-2% -$601K 0.71% 39
2025
Q4
$34.8M Sell
424,514
-38,549
-8% -$3M 0.66% 36
2025
Q3
$34.8M Sell
463,063
-52,405
-10% -$3.91M 0.72% 34
2025
Q2
$38.2M Sell
515,468
-8,946
-2% -$623K 0.84% 29
2025
Q1
$42.3M Hold
524,414
0.95% 26
2024
Q4
$41M Sell
524,414
-7,553
-1% -$642K 0.79% 27
2024
Q3
$49.9M Buy
531,967
+10,950
+2% +$919K 0.81% 31
2024
Q2
$40.6M Buy
521,017
+8,787
+2% +$717K 0.66% 42
2024
Q1
$46.6M Sell
512,230
-22,954
-4% -$1.91M 0.71% 44
2023
Q4
$41.4M Buy
535,184
+522,684
+4,181% +$36.6M 0.63% 50
2023
Q3
$851K Buy
+12,500
New +$909K 0.01% 133

Other funds holding GEHC

Bellevue Group's GEHC Position: Q2 2026 in Review

Bellevue Group reduced its GE HealthCare (GEHC) stake by 39% in Q2 2026, selling an estimated $10.8M and leaving 252,744 shares worth $16.2M. The position accounts for 0.34% of the portfolio, ranked #59.

Bellevue Group first reported a position in GEHC in Q3 2023 and has held it in 12 quarters since. The position peaked at $49.9M in Q3 2024. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Bellevue Group held 252,744 shares of GE HealthCare worth $16.2M as of Q2 2026.
  • Bellevue Group sold 164,143 GE HealthCare shares in Q2 2026, an estimated $10.8M.
  • GE HealthCare made up 0.34% of Bellevue Group's portfolio in Q2 2026, its #59 holding.
  • Bellevue Group first reported a position in GE HealthCare in Q3 2023 and has held it in 12 quarters since.
  • Bellevue Group's GE HealthCare position peaked at $49.9M in Q3 2024.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Bellevue Group's 13F filing for Q2 2026, filed 14 Aug 2026.